Prasugrel, a Third-Generation P2Y12 Receptor Antagonist, in Patients With Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention: Phase III, Randomized, Double-Blind Study
Circulation Journal, 2014/11/25, Vol.78(12), pp.2926-2934 [Peer Reviewed Journal]2014 THE JAPANESE CIRCULATION SOCIETY ;ISSN: 1346-9843 ;EISSN: 1347-4820 ;DOI: 10.1253/circj.CJ-14-0266
Full text available